{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:10:49Z","timestamp":1792714249004,"version":"4.5.0"},"reference-count":111,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["J Clin Oncol"],"published-print":{"date-parts":[[2026,3,10]]},"abstract":"<jats:p>Clinical trials and real-world evidence have established the benefit of chimeric antigen receptor (CAR) T-cell therapy to reduce progression of hematologic malignancies and, in some settings, increase overall survival. However, recent studies have highlighted that patients in long-term remission remain at risk of morbidity and nonrelapse mortality, primarily because of infections and subsequent myeloid malignancies. In addition, these patients may also be survivors of chemotherapy, radiation, and\/or stem-cell transplant, with broad survivorship needs. Here, we provide a roadmap for the care of patients in long-term remission after CAR-T-cell therapies and discuss avenues for future research.<\/jats:p>","DOI":"10.1200\/jco-25-02087","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:59:49Z","timestamp":1770843589000},"page":"698-708","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies"],"prefix":"10.1200","volume":"44","author":[{"given":"Rawan G.","family":"Faramand","sequence":"first","affiliation":[{"name":"Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoer","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-1257","authenticated-orcid":true,"given":"Michael D.","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02786"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01365"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01379-0"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00642"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00321"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113445"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101287"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03084-6"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010624"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.015"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.03.023"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.72"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009117"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01756-w"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010524"},{"key":"e_1_3_4_17_2","first-page":"2307","article-title":"Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma","volume":"141","author":"Neelapu SS","year":"2023","unstructured":"Neelapu SS, Jacobson CA, Ghobadi A, et al: Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma. Blood 141:2307-2315, 2023","journal-title":"Blood"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004603"},{"key":"e_1_3_4_19_2","first-page":"2460","article-title":"How I treat cytopenias after CAR T-cell therapy","volume":"141","author":"Jain T","year":"2023","unstructured":"Jain T, Olson TS, Locke FL: How I treat cytopenias after CAR T-cell therapy. Blood 141:2460-2469, 2023","journal-title":"Blood"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000957"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012522"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-1587"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02605-7"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00629-1"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008320"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.07.002"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-6367(21)00096-8"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.07.018"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002732"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30429-4"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.01.010"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005616"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae291"},{"key":"e_1_3_4_35_2","volume-title":"IDSA 2025 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients","author":"Infectious Diseases Society of America","unstructured":"Infectious Diseases Society of America: IDSA 2025 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients. https:\/\/www.idsociety.org\/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients\/"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238634"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004000"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-822940"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad708"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012922"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1309533"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281719"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694356"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.08.011"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"e_1_3_4_46_2","first-page":"e146743","article-title":"Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies","volume":"6","author":"Walti CS","year":"2021","unstructured":"Walti CS, Krantz EM, Maalouf J, et al: Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies. JCI Insight 6:e146743, 2021","journal-title":"JCI Insight"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01795-3"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14109"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18909"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01521-5"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028833"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020578"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.003"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004475"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010543"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00077-2"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adu9790"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI194631"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025910"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19822"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.023"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004554"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01337-8"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005747"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0177"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025015981"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026236"},{"key":"e_1_3_4_68_2","unstructured":"https:\/\/www.german-lymphoma-alliance.de\/Scores.html"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-460170"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25285169204.x"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017015"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008042"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.05.012"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016346"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008066"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.01.887"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01301-8"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300213"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02767-w"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02826-w"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013243"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401361"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401530"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2504588"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.02.011"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008226"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.038"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009766"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.001"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.10.006"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.4105"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012549"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00715-0"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025679"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024028172"},{"key":"e_1_3_4_98_2","first-page":"2443","article-title":"How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity","volume":"141","author":"Santomasso BD","year":"2023","unstructured":"Santomasso BD, Gust J, Perna F: How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity. Blood 141:2443-2451, 2023","journal-title":"Blood"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14239"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020571"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01167-8"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.09.013"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015478"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198053"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.015"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0487"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012727"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21655"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31030"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.06.002"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000422"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03513-0"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-25-02087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:59:23Z","timestamp":1772751563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-25-02087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,3,10]]}},"alternative-id":["10.1200\/JCO-25-02087"],"URL":"https:\/\/doi.org\/10.1200\/jco-25-02087","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"2025-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}